CPMV fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Mosaic ImmunoEngineering, Inc. is a development-stage biotechnology company, which engages in the development of immunotherapies for the treatment of cancer. Its pipelines include human and veterinary immuno-oncology programs. The company was founded by Steven King, Paul Lytle, Nicole F. Steinmetz, Jonathan K. Pokorski, Steven N. Fiering, and Robert Garnick on August 21, 2020 and is headquartered in Huntington Beach, CA.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
CPMV has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company